APA (7th ed.) Citation

Pencharz, D., Modi, S., Bandyopadhyay, S., Alhun, U., Marchbank, N., Patel, A., & Wagner, T. (2022). Absence of clinical benefit of FDG PET-CT in staging T1 part-solid lung adenocarcinoma. Clinical Radiology, 77(3), 195. https://doi.org/10.1016/j.crad.2021.11.013

Chicago Style (17th ed.) Citation

Pencharz, D., S. Modi, S. Bandyopadhyay, U. Alhun, N. Marchbank, A. Patel, and T. Wagner. "Absence of Clinical Benefit of FDG PET-CT in Staging T1 Part-solid Lung Adenocarcinoma." Clinical Radiology 77, no. 3 (2022): 195. https://doi.org/10.1016/j.crad.2021.11.013.

MLA (9th ed.) Citation

Pencharz, D., et al. "Absence of Clinical Benefit of FDG PET-CT in Staging T1 Part-solid Lung Adenocarcinoma." Clinical Radiology, vol. 77, no. 3, 2022, p. 195, https://doi.org/10.1016/j.crad.2021.11.013.